Cannabis use and cognitive impairment in schizophrenia

INTRODUCTION: Neurocognitive deficits amongst patients with schizophrenia are considered one of schizophrenia’s central features. These deficits appear to be present from the first episode of psychosis (FEP) and certain cognitive impairments could be components of a genetic vulnerability to schizoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, M., Romão, J., André, R., Félix, F., Andrade, G., Saraiva, R., Dornelles, E., Fernandes, E., Abreu, M., Chendo, I., Ismail, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566952/
http://dx.doi.org/10.1192/j.eurpsy.2022.1158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566952/
http://dx.doi.org/10.1192/j.eurpsy.2022.1158

Ejemplares similares